Larry R Ellingsworth

Title: Larry R Ellingsworth: Innovator in Toxin Neutralization

Introduction

Larry R Ellingsworth is a notable inventor based in Rockville, MD (US). He holds a total of 6 patents that contribute significantly to the field of toxin neutralization. His work focuses on isolated polypeptides derived from toxin A and toxin B proteins, which have important applications in medical science.

Latest Patents

Among his latest patents is the invention of isolated polypeptides of the toxin A and toxin B proteins. This invention provides C-TAB.G5 and C-TAB.G5.1 isolated polypeptides that comprise the receptor binding domains of toxin A and toxin B, as detailed in the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 4. These isolated polypeptides are designed to neutralize the toxic effects of toxin A and/or toxin B, showcasing the potential for therapeutic applications.

Career Highlights

Throughout his career, Larry has worked with prominent companies such as Valneva Austria GmbH and Valneva USA, Inc. His contributions to these organizations have been instrumental in advancing research and development in the field of toxin neutralization.

Collaborations

Larry has collaborated with notable colleagues, including David Flyer and Jing-Hui Tian. These partnerships have enhanced his research efforts and contributed to the success of his inventions.

Conclusion

Larry R Ellingsworth is a distinguished inventor whose work in toxin neutralization has made a significant impact in the field. His innovative patents and collaborations reflect his commitment to advancing medical science.